Dose-Modifying Factor of Radiation Therapy with Concurrent Cisplatin Treatment in HPV-Positive Squamous Cell Carcinoma: A Preclinical Study
Ajda Prevc(Institute of Oncology Ljubljana), Gregor Serša(University of Ljubljana), Blaž Grošelj(Institute of Oncology Ljubljana), Margareta Strojan Fležar(University of Ljubljana), Primož Strojan(Institute of Oncology Ljubljana), Irena Srebotnik Kirbiš(University of Ljubljana), Matjaž Novak(Ecological Engineering Institute), Metka Filipič(National Institute of Biology), Mario Poljak(University of Ljubljana), Simona Kranjc(University of Ljubljana), Vesna Todorović(Institute of Oncology Ljubljana), Andreja Brožič(Institute of Oncology Ljubljana), Maja Čemažar(University of Primorska), Ana Rotter(National Institute of Biology), Lea Hošnjak(University of Ljubljana), Martina Nikšić Žakelj(Institute of Oncology Ljubljana), Bojana Žegura(National Institute of Biology)
Cited by 18
Related Papers
Titanium dioxide in our everyday life; is it safe?
|Radiology and Oncology|2011|545
Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases
|Acta Oncologica|2018|387
Marine Environmental Plastic Pollution: Mitigation by Microorganism Degradation and Recycling Valorization
|Frontiers in Marine Science|2020|235